Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection
Clinical trial NCT05196477 · COMPLETED
Trial details
- NCT number
- NCT05196477
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-14
- Primary completion
- 2022-08-29
- Enrollment
- 3087
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.